Related references
Note: Only part of the references are listed.Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma
Keinosuke Ishido et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Ductal Adenocarcinoma
Koji Kubota et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Systemic inflammation response index correlates with survival and predicts oncological outcome of resected pancreatic cancer following neoadjuvant chemotherapy
Ji Su Kim et al.
PANCREATOLOGY (2022)
Estimated Projection of US Cancer Incidence and Death to 2040
Lola Rahib et al.
JAMA NETWORK OPEN (2021)
Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma
Kyohei Yugawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Updated Trends in Cancer in Japan: Incidence in 1985-2015 and Mortality in 1958-2018-A Sign of Decrease in Cancer Incidence
Kota Katanoda et al.
JOURNAL OF EPIDEMIOLOGY (2021)
Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study
Shinji Itoh et al.
PANCREATOLOGY (2021)
A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma
Shi-wei Guo et al.
SURGERY (2020)
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
David T. Pointer et al.
BMC CANCER (2020)
Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2019)
Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer
Manabu Kawai et al.
SURGERY (2019)
A combination of platelet-to-lymphocyte ratio and carbohydrate antigen 19-9 predict early recurrence after resection of pancreatic ductal adenocarcinoma
Shinichi Ikuta et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Role of the tumor microenvironment in pancreatic cancer
Takashi Murakami et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Fuyuhiko Motoi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery
Jinming Yu et al.
MEDICINE (2018)
Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients
Sang Hyun Shin et al.
SURGERY (2018)
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2018)
Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer
Zuqiang Liu et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer
Marek Sierzega et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Pancreatic Adenocarcinoma, Version 2.2017
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
Claudio Bassi et al.
SURGERY (2017)
Preoperative predictors for early recurrence of resectable pancreatic cancer
Kohei Nishio et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies
Han-Xiang Zhan et al.
CANCER MEDICINE (2017)
Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer
Joji Watanabe et al.
SURGERY TODAY (2016)
The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection
Koichiro Haruki et al.
WORLD JOURNAL OF SURGERY (2016)
Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study
Ippei Matsumoto et al.
PANCREATOLOGY (2015)
Optimal duration of the early and late recurrence of pancreatic cancer after pancreatectomy based on the difference in the prognosis
Yusuke Yamamoto et al.
PANCREATOLOGY (2014)
Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma
Teiichi Sugiura et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
CA 19-9 LEVEL AS INDICATOR OF EARLY DISTANT METASTASIS AND THERAPEUTIC SELECTION IN RESECTED PANCREATIC CANCER
Tae Hyun Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Youden index and optimal cut-point estimated from observations affected by a lower limit of detection
Marcus D. Ruopp et al.
BIOMETRICAL JOURNAL (2008)
Share Paper
